Sign in
Active, not recruitingNo phase

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
30 people, planned
Started
19 Nov 2022
Ended
23 Mar 2026
Type of study
Interventional
Treatments tested
  • RLRL
Record updated
30 March 2025

Who can take part

Age
6 years to 16 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Provision of consent
  • Age: ≥ 6 and ≤ 16 years at enrolment
  • High myopia: cycloplegic sphere ≤ -6.00 diopters (D) in both eyes
  • Willing and able to participate in all required activities of the study
  • The children currently on myopia control treatment can be recruited if myopia control treatments (including but not limited to atropine, orthokeratology, rigid gas-permeable lenses, defocus spectacles, etc.) are discontinued for at least 2 weeks
  • Normal fundus, tessellated fundus or with peripapillary diffuse chorioretinal atrophy

Who cannot take part

  • Previous any intraocular surgery affecting refractive status
  • Secondary myopia, such as a history of retinopathy of prematurity or neonatal problems, or syndromic myopia with a known genetic disease or connective tissue disorders, such as Stickler or Marfan syndrome
  • Pathologic myopia with signs of macula-involving diffuse chorioretinal atrophy, patchy chorioretinal atrophy, macular atrophy, lacquer cracks, myopic choroidal neovascularization or Fuchs' spots
  • Strabismus and binocular vision abnormalities in either eye
  • Other reasons, including but not limited to ocular or other systemic abnormalities, that the physician may consider inappropriate for enrolment

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this clinical trial is to confirm the incidence and magnitude of axial length shortening after RLRL therapy in Chinese high myopia children and teenagers.

The group in the trial

  • RLRL therapyTreatment being tested

    In addition to SVS, participants will be treated with RLRL twice a school day.

    Treatment: RLRL

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Repeated Low-Level Red-Light Therapy for Shortening Axial Length in Chinese High Myopia Children and Teenagers: a Prospective Single-Arm Study
Record updated
30 March 2025